Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,551 | -19,024 | -15,422 | -11,270 | -6,690 |
| Depreciation Amortization | 584 | 2,191 | 1,592 | 1,059 | 495 |
| Accounts receivable | 2,933 | -3,702 | -1,451 | -348 | -577 |
| Accounts payable and accrued liabilities | 1,128 | -1,815 | -978 | -722 | -189 |
| Other Working Capital | 2,605 | -4,759 | -3,222 | -2,471 | -1,431 |
| Other Operating Activity | -4,583 | 9,631 | 5,502 | 3,109 | 1,749 |
| Operating Cash Flow | $-884 | $-17,478 | $-13,979 | $-10,643 | $-6,643 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -698 | -2,384 | -1,621 | -1,239 | -397 |
| Purchase Of Investment | -7,414 | -35,385 | -27,705 | -22,365 | -19,393 |
| Sale Of Investment | 10,507 | 51,770 | 45,770 | 34,760 | 24,360 |
| Investing Cash Flow | $2,395 | $14,001 | $16,444 | $11,156 | $4,570 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,875 | 1,875 | 1,875 | N/A |
| Debt Repayment | N/A | -12,065 | -10,190 | -7,353 | -3,818 |
| Common Stock Issued | 1,767 | 58,711 | 58,268 | 1,306 | 780 |
| Financing Cash Flow | $1,767 | $48,521 | $49,953 | $-4,172 | $-3,038 |
| Exchange Rate Effect | -112 | 52 | 40 | -40 | 54 |
| Beginning Cash Position | 58,649 | 13,553 | 13,553 | 13,553 | 13,553 |
| End Cash Position | 61,815 | 58,649 | 66,011 | 9,854 | 8,496 |
| Net Cash Flow | $3,166 | $45,096 | $52,458 | $-3,699 | $-5,057 |
| Free Cash Flow | |||||
| Operating Cash Flow | -884 | -17,478 | -13,979 | -10,643 | -6,643 |
| Capital Expenditure | -698 | -2,384 | -1,621 | -1,239 | -397 |
| Free Cash Flow | -1,582 | -19,862 | -15,600 | -11,882 | -7,040 |